Introduction
In cystic fibrosis (CF), acute and chronic respiratory tract infections are the principle cause of progressive decline in respiratory function [1] [2] [3] . Staphylococcus aureus, Haemophilus influenzae and Pseudomonas aeruginosa are the most common pathogens isolated from sputum of CF patients 1 . Another group of organisms frequently isolated from CF respiratory samples are thermotolerant filamentous fungi 4, 5 
such as Aspergillus fumigatus, Scedosporium apiospermum
and Aspergillus terreus 4 . Most studies have focused on A. fumigatus and variable detection rates ranging from 5.9 to 58.3% 6, 7 have been reported, likely the result of differences in the sputum sampling technique and the microbiological processing of samples 8, 9 .
Fungi can cause problems in cystic fibrosis in two ways: 1) a hypersensitivity reaction to A.
fumigatus including the development of allergic bronchopulmonary aspergillosis (ABPA) 10, 11 ; 2)
Aspergillus bronchitis: infection with A. fumigatus, in the absence of ABPA may cause respiratory deteriorations that do not respond to antibiotic treatment, but to antifungal therapy 5 .
Colonisation of the airways with A. fumigatus has been found to be associated with age in some studies 6, 12 but colonisation may be underestimated in younger children when relying on cough swabs from non-sputum-producing subjects. We undertook an 8-year retrospective cohort analysis of paediatric CF patients to study the rate of A. fumigatus airway colonisation, determine the sensitivity of different techniques of sputum sampling at detecting A. fumigatus, and to compare the lung function of colonised versus non-colonised children. 
Materials and Methods

Patient population and study design:
Statistics:
The clinical data is presented as medians and ranges. Comparisons between groups were made using Mann-Whitney U test and Fisher's exact test. A p-value of <0.05 was considered significant.
Results
Data were available and reviewed for 1024 respiratory specimens from 45 children. Specimens comprised 976 sputum samples from 38 patients, and 48 BAL samples from 29 patients. The median patient age for sputum sampling was 11.5 years, compared to a median patient age of 6.6 years for BAL samples. Twenty-two children (49%) had both sputum and BAL samples, 16 (35%) had sputum only, and seven (16%) had BAL sampling only. The demographic data of the study participants is shown in Table 1 .
Microbiology:
Nineteen children (42%) had a positive A. fumigatus culture at least once during the study period, of whom ten (22% of cohort) were "persistently", and nine (20% of cohort) "transiently" colonised. The median age at first A. fumigatus-positive culture was 9.0 years (range 3.1 -16.2 years), and it was observed that most of the children over 10 years of age were persistently colonised with A. fumigatus (Figure 1) . A. fumigatus was the third most commonly isolated organism in our paediatric CF cohort. Other organisms isolated are presented in the online supplement.
A. fumigatus was cultured from a greater proportion of BAL samples (29%) compared
with sputum samples (14%). There were eight instances where BAL and sputum were sampled in the same A. fumigatus-positive child within two weeks of one another; six of these matched samples were BAL-positive and sputum-negative, one was BAL-negative and sputum-positive, and one was both BAL and sputum-positive. fumigatus isolated during the study period.
Immunology
Lung function:
Lung function data were available for 33 patients; the remaining 12 patients were too young to perform reliable spirometry testing. Patients were classified as having "severe" or "non-severe" lung disease (Figure 2 ) according to the longitudinal observational data of Schluchter et al. 17 , where "severe" approximates to the lowest quartile of FEV 1 % predicted for age. Seven children from our cohort were classed as having severe lung disease. Of these, five were colonised with A. fumigatus (four persistently) of whom four were also sensitised to A.
fumigatus with one meeting the criteria for a clinical diagnosis of ABPA. Two children with severe lung disease were neither colonised nor sensitised. In 31 children for whom lung function and immunological data were available, we found no significant difference in FEV 1 %predicted between the Aspergillus-sensitised (n=17) and non-sensitised (n=14) children.
Duration of colonisation:
Ten children had "persistent" A. fumigatus colonisation during the study period of whom two were colonised for less than one year. The other eight were colonised over periods ranging from 3.3 to 7.6 years. Duration of A. fumigatus colonisation was not associated with severity of lung disease but the number of subjects was too small to perform a meaningful subgroup analysis.
Discussion
A. fumigatus is one of the most common organisms isolated from the sputum of CF patients
and colonisation has been associated with worse CF lung disease 7,18 and more frequent respiratory exacerbations 14 . However, very little data is available in young children with CF and differences in isolation rates between sampling techniques have not been studied.
We cultured A. fumigatus from the respiratory tract in nearly half of our study population over the 8-year study period with 22% of children fulfilling criteria for persistent A.
fumigatus colonisation 7 . These findings are similar to recent data reported from France 19 although that study only included children who were able to spontaneously expectorate sputum.
Previous studies reported an association between age and risk of Aspergillus sp. isolation 6 , however, these studies tended to rely on sputum-producing children and this may underestimate the presence of A. fumigatus in younger children. We found that A. Moreover, data on A. fumigatus isolation from sputum is not routinely collected by many national CF databases including the UK CF Trust.
Conclusions
In our practice, BAL appears superior at detecting lower airway A. fumigatus compared to sputum samples, therefore the presence of this organism may be underestimated, particularly in young children. The clinical significance of A. fumigatus sensitisation with or without airway colonisation is poorly understood, but it is possible that current practice may not be providing the optimum treatment for this subgroup of CF patients. Larger prospective observational studies are needed to elucidate the clinical relevance of A. fumigatus sensitisation and colonisation in the absence of ABPA to inform the clinical management of these patients. 
